Donal, John B.
HRN: 22-47-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/16/2023
01/23/2023
IV
150 Mg
Q24
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes